| ²é¿´: 340 | »Ø¸´: 2 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷ÕßlwjxzÔö¼Ó½ð±Ò 1.5 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
lwjxzľ³æÖ®Íõ (ÖªÃû×÷¼Ò)
|
[×ÊÔ´]
¡¾×ªÌû¡¿ÃÀ¹úÐÂÒ©×¢²áÖÆ¶È¼°ÆäÓëÖйúÏà¹ØÖÆ¶ÈµÄ±È½ÏÑо¿£¨ÓÐÒ»¶¨µÄ²Î¿¼×÷Óã©
|
|
|
2003ÄêµÄ±È½ÏÔ磬µ«ÓÐÒ»¶¨µÄ²Î¿¼ÒâÒå¡£ Ä¿ ¼ ÖÐÎÄÕªÒª Ó¢ÎÄÕªÒª ²ÄÁÏÓë·½·¨ ǰÑÔ µÚÒ»²¿·ÖFDAµÄ×éÖ¯»ú¹¹ µÚ¶þ²¿·ÖÑо¿ÓÃÐÂÒ©µÄÉêÇ루Investigational New Drug Application,IND£© µÚÈý²¿·ÖÁÙ´²Ñо¿µÄÉóÅú µÚËIJ¿·ÖÐÂÒ©Éú²úÉÏÊеÄÉêÇ루New Drug Application,NDA£© µÚÎ岿·Ö¼òÂÔÉêÇ루Abbreviated New Drug Application,ANDA£© µÚÁù²¿·ÖÆäËûÉêÇë µÚÆß²¿·ÖרÀû×ÊÁÏ µÚ°Ë²¿·ÖÐÂÒ©ÉóÆÀ³ÌÐò£¨New Drug Application review process£© µÚ¾Å²¿·ÖÊг¡¶ÀռȨ£¨Exclusivity£© µÚÊ®²¿·ÖÖÐÃÀÐÂÒ©ÉóÅúÖÆ¶ÈµÄ±È½Ï Ò»¡¢ÁÙ´²Ñо¿ÉóÅúµÄ¶Ô±È ¶þ¡¢ÐÂÒ©Éú²úÉÏÊÐÉóÅúµÄ¶Ô±È Èý¡¢·ÂÖÆÒ©ÉóÆÀµÄ¶Ô±È ËÄ¡¢²¹³äÉêÇëµÄ¶Ô±È Îå¡¢ÐÂÒ©±£»¤Õþ²ßµÄ¶Ô±È ½áÂÛ ²Î¿¼ÎÄÏ× ¹úÍâÐÂÒ©×¢²áÖÆ¶ÈµÄÏÖ×´ ÖÂл ÂÛÎĶÀ´´ÐÔÉùÃ÷¼°ÂÛÎÄʹÓÃÊÚȨÉùÃ÷ ÏÂÔØ£ºhttp://ishare.iask.sina.com.cn/f/6359997.html http://ishare.iask.sina.com.cn/f/6359997.html [ Last edited by lwjxz on 2009-12-29 at 13:59 ] |
» ²ÂÄãϲ»¶
¼û¿¯¿ìµÄÖÐÎĺËÐÄÆÚ¿¯
ÒѾÓÐ2È˻ظ´
Ò»Ö¾Ô¸ÌìÖÐÒ½ÖÐҩѧר˶£¬Ï£ÍûÓÐbÇøµÄÀÏʦ¿ÉÒÔ¿¼ÂÇÒ»ÏÂÎÒ
ÒѾÓÐ1È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ193È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
26Ä격ʿÉêÇë
ÒѾÓÐ20È˻ظ´
ÇóÖú ±½Á×Áò°·JP
ÒѾÓÐ0È˻ظ´
100½ð±Ò °¢ÄªÎ÷ÁÖ¿ËÀάËá¼ØÆ¬BPÒ©µäÖÐÌáµ½µÄ¿ËÀάËá¾ÛºÏÎï¾ßÌå½á¹¹Ê½ÊÇɶ£¿
ÒѾÓÐ2È˻ظ´
ÉÅʳ²¹³ä¼ÁºÏ¹æÐÔ½»Á÷
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸Õã´óҩѧÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
¸ßθßѹ·´Ó¦ÇóÖú
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
2Â¥2009-12-29 15:17:53
3Â¥2009-12-29 15:24:38














»Ø¸´´ËÂ¥